Kala Bio (KALA) Inventory (2018 - 2022)
Kala Bio (KALA) posted Inventory of $25000.0 for Q2 2022, down 99.76% sequentially from $10.5 million in Q1 2022, and down 99.69% YoY from $8.0 million in Q2 2021.
Kala Bio (KALA) Inventory (2018 - 2022) Analysis & Trends
Kala Bio has reported Inventory for 5 years, with the latest figure at $25000.0 in Q2 2022.
- Quarterly Inventory fell 99.69% year-over-year to $25000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $25000.0 (down 99.69% YoY) and the FY2021 annual result came in at $8.6 million, up 65.21% from the prior year.
- Inventory retreated to $25000.0 in Q2 2022 per KALA's latest filing, from $10.5 million in the prior quarter.
- Over five years, Inventory peaked at $10.5 million in Q1 2022 and troughed at $25000.0 in Q2 2022.
- A 5-year average of $6.0 million and a median of $5.6 million in 2019 frame the typical range for Inventory.
- The sharpest annual moves came in 2019 and 2022: Inventory surged 469.36% in 2019, then tumbled 99.69% in 2022.
- Over 5 years, Inventory stood at $4.1 million in 2018, then rose by 13.5% to $4.6 million in 2019, then increased by 12.5% to $5.2 million in 2020, then jumped by 65.21% to $8.6 million in 2021, then tumbled by 99.71% to $25000.0 in 2022.
- According to Business Quant data, Inventory over the past three periods registered $25000.0, $10.5 million, and $8.6 million for Q2 2022, Q1 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | - |
| 10 | Kala Bio | 10.00 Mn | 10.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 10.53 Mn |
| Dec 31, 2021 | 8.64 Mn |
| Sep 30, 2021 | 7.71 Mn |
| Jun 30, 2021 | 8.05 Mn |
| Mar 31, 2021 | 8.24 Mn |
| Dec 31, 2020 | 5.23 Mn |
| Sep 30, 2020 | 7.54 Mn |
| Jun 30, 2020 | 5.71 Mn |
| Mar 31, 2020 | 5.27 Mn |
| Dec 31, 2019 | 4.65 Mn |
| Sep 30, 2019 | 5.56 Mn |
| Jun 30, 2019 | 8.22 Mn |
| Mar 31, 2019 | 5.42 Mn |
| Dec 31, 2018 | 4.10 Mn |
| Sep 30, 2018 | 976,000.00 |